Buscar
Mostrando ítems 1-10 de 994
Handbook of Pharmaceutical excipients
(Libros Digitales - Pharmaceutical Press, 2009)
Pharmaceutical dosage forms contain both pharmacologically
active compounds and excipients added to aid the formulation
and manufacture of the subsequent dosage form for administration
to patients. Indeed, the properties ...
Development and analysis of formulations to the delivery of caffeine for the treatment of gynoid lipodystrophy
(2014)
This study aimed to investigate the kinetics of the in vitro release of caffeine in various excipients, and to perform the rheological characterization of these excipients. In vitro release experiments were performed using ...
Avaliacao preliminar da utilizacao do residuo industrial de man dioca (manihot esculenta granz) como excipiente em comprimidos: Caracteristicas fisicas e de compressao
(1998-01-01)
The applicability of a residue of manioc (Manihot esculenta Granz) from industrial processing as a direct compression excipient was investigated in comparison with microcrystalline cellulose (Avicel® PH 101). Physical ...
Drug Excipient Interaction Study with Polymorphic Forms of Tibolone
(COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES, 2010)
Powder mixtures (1:1) of tibolone polymorphic forms I (monoclinic) and II (triclinic) and excipients have been prepared and compacted. The samples were stored at 50 degrees C and 90% RH for one month and subsequently were ...
Evaluation of mucilages isolated from seeds of Hyptis suaveolens, Salvia hispanica and Linum usitatissimum as pharmaceutical excipients in solid dose and liquid formulations
(2018)
In this work, the performance of mucilages obtained from the seeds of Hyptis suaveolens, Linum usitatissimum and salvia hispanica were evaluated for their potential use as stabilizers in liquid formulations and as binders ...
Chemometric study of the excipients’ influence on polymorphic-behavior: Mefenamic acid as case of study
(Elsevier Science, 2019-06)
The assessment of polymorphism is a problematical issue for regulatory agencies, because variations among crystalline forms of active pharmaceutical ingredient (API) can lead to changes in the efficacy and safety of ...